Lumen Bioscience
PrivateLast Round
Series C
Extension
Oct 8, 2025
Total Funding Raised
$126.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lumen Bioscience is a biotechnology company that develops oral biologic drugs and vaccine candidates using a proprietary spirulina-based platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Clean Manufacturing
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumen Bioscience Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Lumen Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Oct 8, 2025 | ||||
| Grant | Oct 17, 2023 | ||||
| Series C | Jun 1, 2022 | ||||
| Grant | Jan 27, 2021 | ||||
| Series B | Sep 1, 2020 | ||||
Grant | Dec 5, 2017 |
Lumen Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| U.S. Department of Defense | Grant |
| Gates Family Foundation | Series C Extension |
| Gates Foundation | Grant, Series C Extension |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| WestRiver Group | Series C Extension, Series B |
| U.S. Department of War | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
Achieved FSCC 22000 food safety certification.
- Oct 8, 2025
Jeff Raikes, former Microsoft president, joins the board.
Lumen Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lumen Bioscience's valuation, stock price, and market status.